California Public Employees Retirement System
VNDA icon

California Public Employees Retirement System’s Vanda Pharmaceuticals VNDA Stock Holding History

California Public Employees Retirement System’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-109,700
Closed -$1.65M – 2887
2021
Q1 		$1.65M Sell
109,700
-9,731
-8% -$158K ﹤0.01% 2149
2020
Q4 		$1.57M Sell
119,431
-3,083
-3% -$37.1K ﹤0.01% 2158
2020
Q3 		$1.18M Buy
122,514
+3,300
+3% +$35.3K ﹤0.01% 2156
2020
Q2 		$1.36M Buy
119,214
+3,538
+3% +$40.1K ﹤0.01% 2016
2020
Q1 		$1.2M Sell
115,676
-74,500
-39% -$924K ﹤0.01% 1902
2019
Q4 		$3.12M Buy
190,176
+121,700
+178% +$1.84M ﹤0.01% 1771
2019
Q3 		$909K Buy
68,476
+11,862
+21% +$165K ﹤0.01% 2318
2019
Q2 		$798K Buy
56,614
+1,200
+2% +$19.1K ﹤0.01% 2294
2019
Q1 		$1.02M Sell
55,414
-11,571
-17% -$264K ﹤0.01% 2208
2018
Q4 		$1.75M Buy
66,985
+1,613
+2% +$37.9K ﹤0.01% 1811
2018
Q3 		$1.5M Buy
65,372
+5,379
+9% +$110K ﹤0.01% 2093
2018
Q2 		$1.14M Sell
59,993
-2,905
-5% -$48.6K ﹤0.01% 2243
2018
Q1 		$1.06M Buy
62,898
+1,726
+3% +$28.9K ﹤0.01% 2264
2017
Q4 		$930K Hold
61,172
– – ﹤0.01% 2363
2017
Q3 		$1.09M Buy
61,172
+1,572
+3% +$26.3K ﹤0.01% 2249
2017
Q2 		$971K Buy
59,600
+2,200
+4% +$31.7K ﹤0.01% 2290
2017
Q1 		$804K Sell
57,400
-6,200
-10% -$88.4K ﹤0.01% 2424
2016
Q4 		$1.01M Sell
63,600
-3,000
-5% -$48.2K ﹤0.01% 2308
2016
Q3 		$1.11M Sell
66,600
-4,400
-6% -$59.2K ﹤0.01% 2275
2016
Q2 		$795K Buy
71,000
+1,600
+2% +$15.5K ﹤0.01% 2479
2016
Q1 		$580K Sell
69,400
-4,300
-6% -$35.3K ﹤0.01% 2654
2015
Q4 		$686K Hold
73,700
– – ﹤0.01% 2621
2015
Q3 		$831K Hold
73,700
– – ﹤0.01% 2480
2015
Q2 		$935K Hold
73,700
– – ﹤0.01% 2534
2015
Q1 		$879K Hold
73,700
– – ﹤0.01% 2659
2014
Q4 		$879K Hold
73,700
– – ﹤0.01% 2659
2014
Q3 		$765K Sell
73,700
-7,500
-9% -$98.3K ﹤0.01% 2688
2014
Q2 		$1.31M Buy
81,200
+7,500
+10% +$99.9K ﹤0.01% 2377
2014
Q1 		$1.1M Hold
73,700
– – ﹤0.01% 2469
2013
Q4 		$900K Sell
73,700
-1,300
-2% -$13.1K ﹤0.01% 2631
2013
Q3 		$823K Hold
75,000
– – ﹤0.01% 2506
2013
Q2 		$606K Buy
+75,000
New +$505K ﹤0.01% 2566

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

California Public Employees Retirement System's VNDA Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Vanda Pharmaceuticals (VNDA) in Q2 2021, closing a stake of 109,700 shares — an estimated $1.65M sold.

California Public Employees Retirement System first reported a position in VNDA in Q2 2013 and held it in 32 quarters. The position peaked at $3.12M in Q4 2019. 181 funds tracked by Wall St. Rank hold VNDA as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Vanda Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 109,700 Vanda Pharmaceuticals shares in Q2 2021, an estimated $1.65M.
  • California Public Employees Retirement System first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 32 quarters.
  • California Public Employees Retirement System's Vanda Pharmaceuticals position peaked at $3.12M in Q4 2019.
  • 181 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.